The document discusses ways for pharmaceutical companies to adopt a more patient-centric approach. It suggests that companies focus on understanding patient data, inviting patients to speak at events to understand their perspectives, and training medical representatives to better explain diseases and treatments to patients. While patient-centric care is ideal, companies face challenges balancing business pressures with patient needs. The document proposes that companies discover unmet patient needs, reduce patient burdens like affordability and convenience issues, identify both physician and patient needs separately, and perfect integrated care delivery between marketing, hospitals and patient programs.